These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20652818)

  • 1. CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency.
    Bouts AH; Roofthooft MT; Salomons GS; Davin JC
    Pediatr Nephrol; 2010 Dec; 25(12):2547-8. PubMed ID: 20652818
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.
    Reid VL; Mullan A; Erwig LP
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24005975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome.
    Davin JC; Buter N; Groothoff J; van Wijk J; Bouts A; Strain L; Goodship T
    Pediatr Nephrol; 2009 Sep; 24(9):1757-60. PubMed ID: 19373492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
    Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
    Sharma AP; Greenberg CR; Prasad AN; Prasad C
    Pediatr Nephrol; 2007 Dec; 22(12):2097-103. PubMed ID: 17874135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.
    Provaznikova D; Rittich S; Malina M; Seeman T; Marinov I; Riedl M; Hrachovinova I
    Pediatr Nephrol; 2012 Jan; 27(1):73-81. PubMed ID: 21706448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.
    Guigonis V; Frémeaux-Bacchi V; Giraudier S; Favier R; Borderie D; Massy Z; Mougenot B; Rosenblatt DS; Deschênes G
    Am J Kidney Dis; 2005 Mar; 45(3):588-95. PubMed ID: 15754282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency.
    Kömhoff M; Roofthooft MT; Westra D; Teertstra TK; Losito A; van de Kar NC; Berger RM
    Pediatrics; 2013 Aug; 132(2):e540-4. PubMed ID: 23837176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and functional analysis of two missense mutations in CD46 predispose to postpartum atypical hemolytic uremic syndrome.
    Wu H; Mao Z; Tan Y; Jiang Y; Yu J; Song L; Wu S; Sun M; Zhu L; Yu X; Zhang L; Yu F; Zhao MH
    Clin Chim Acta; 2020 Apr; 503():61-69. PubMed ID: 31945341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmatherapy in atypical hemolytic uremic syndrome.
    Loirat C; Garnier A; Sellier-Leclerc AL; Kwon T
    Semin Thromb Hemost; 2010 Sep; 36(6):673-81. PubMed ID: 20865645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
    Goodship TH; Liszewski MK; Kemp EJ; Richards A; Atkinson JP
    Trends Mol Med; 2004 May; 10(5):226-31. PubMed ID: 15121049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation in atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Goodship T; Jalanko H
    Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E; Alberti M; Noris M
    J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations.
    Kavanagh D; Goodship TH
    Hematology Am Soc Hematol Educ Program; 2011; 2011():15-20. PubMed ID: 22160007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes.
    Marini SC; Gomes M; Guilherme R; Carda JP; Pinto CS; Fidalgo T; Ribeiro ML
    Blood Coagul Fibrinolysis; 2019 Mar; 30(2):68-70. PubMed ID: 30676336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement regulatory genes and hemolytic uremic syndromes.
    Kavanagh D; Richards A; Atkinson J
    Annu Rev Med; 2008; 59():293-309. PubMed ID: 17705684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.
    Tawadrous H; Maga T; Sharma J; Kupferman J; Smith RJ; Schoeneman M
    Pediatr Nephrol; 2010 May; 25(5):947-51. PubMed ID: 20108004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.